Offer for Subscription - Update

Unicorn AIM VCT PLC
08 February 2024
 

Unicorn AIM VCT plc (the "Company")

LEI: 21380057QDV7D34E9870

Offer for Subscription - Update

 

The Company published a prospectus on 26 January 2024, ("the Prospectus") containing an offer for subscription of up to £15 million with an over-allotment facility for a further £5 million through the subscription of up to a maximum of 30 million ordinary shares of 1p each ("the Offer"). Full details of the Offer are contained in the Prospectus.

 

The Directors of the Company are pleased to announce that on the basis of subscription forms received as at 15.00 Thursday 8 February 2024 and assuming that they are all accepted, the initial £15 million Offer is now fully subscribed.

 

In order to accommodate further unsatisfied demand, and in accordance with the Prospectus, the Board has decided, after consultation with Unicorn Asset Management Limited (UAM), the Company's Investment Manager, to utilise the over-allotment facility and increase the Offer by a further £5 million. The Offer will therefore remain open until 28 March 2024 unless the over-allotment facility is fully subscribed before this date or otherwise at the Board's discretion.

 

8 February 2024

 

For further information please contact:

 

Unicorn Asset Management Limited (the Company's Investment Manager) on

020 7253 0889

 

ISCA Administration Services Limited (the Company Secretary) on

01392 487056; or unicornaimvct@iscaadmin.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings